Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

Elaine Mendonca by Elaine Mendonca
March 15, 2024
in Breaking News
0
Businesses finance
0
SHARES
17
VIEWS
Share on FacebookShare on Twitter

Blackstone Strategic Credit 2027 Term Fund (BGB) has announced a monthly dividend of 9.3 cents per share, to be paid out on March 28, 2024. Shareholders who hold BGB as of the end of trading on Tuesday will qualify for this dividend. The ex-dividend date is on Wednesday, which means the stock is expected to open 9.3 cents lower to adjust for the dividend payout. Investors can choose to reinvest the dividends in BGB or use them for other purposes.

Booz Allen Hamilton Holding Corporation (BAH) Stock Analysis: March 15, 2024 Performance Review

Booz Allen Hamilton Holding Corporation (BAH) had a mixed performance on March 15, 2024, as the stock traded near the top of its 52-week range and above its 200-day simple moving average. Despite these positive indicators, the stock saw a slight decrease in price, closing at $144.79, down $0.38 or 0.26% from the previous trading day.

The fact that BAH is trading near the top of its 52-week range suggests that investors have been bullish on the stock in recent months. Additionally, trading above the 200-day simple moving average is typically seen as a positive sign, indicating that the stock is in an uptrend over the long term.

However, the slight drop in price on March 15 may have been a cause for concern for some investors. It’s worth noting that the stock remained unchanged in after-hours trading, which could indicate that investors are taking a wait-and-see approach before making any significant moves.

Boeing (BAH) Stock Performance Analysis: Mixed Results on March 15, 2024

Boeing Company (BAH) stock performance on March 15, 2024, reflected a mixed bag of financial results. According to data from CNN Money, the aerospace giant reported total revenue of $9.26 billion for the past year, representing a 10.7% increase compared to the previous year. However, the company’s total revenue for the third quarter of the fiscal year stood at $2.57 billion, indicating a 3.62% decrease from the previous quarter.

In terms of net income, Boeing reported a figure of $269.66 million for the past year, which marked a significant 41.84% decrease compared to the previous year. The net income for the third quarter of the fiscal year was $144.43 million, reflecting a 14.68% decrease from the previous quarter.

Earnings per share (EPS) also saw a decline for Boeing, with the company reporting an EPS of $2.03 for the past year, representing a 40.9% decrease compared to the previous year. The EPS for the third quarter of the fiscal year was $1.11, indicating a 14.25% decrease from the previous quarter.

These financial results indicate that Boeing has faced challenges in maintaining its profitability and revenue growth. The decrease in net income and EPS suggests that the company may be experiencing operational difficulties or facing external factors that are impacting its financial performance.

Investors and analysts will be closely monitoring Boeing’s future financial results and performance to assess the company’s ability to overcome these challenges and drive growth in the future. It will be important for Boeing to address any underlying issues and implement strategies to improve its financial performance in order to regain investor confidence and drive stock value growth.

Tags: BAH
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Biotechnology Stock Bull Market
Breaking News

Analyzing Short Interest in Rigetti Computing and Its Peers

March 15, 2024
Next Post
NFT projects

The Impact of TikToks Fate on USChina Relations and American Tech Giants

Real Estate

The Future of Work: How Remote Work Trends are Reshaping Japan's Real Estate Landscape

FPGA Development

Unlocking the Future: The Rise of Open-Source FPGA Development Tools

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com